Tusitala: Gregory Harris
Aso O Foafoaga: 14 Apelila 2021
Faafouga Aso: 18 Novema 2024
Anonim
Mode of action of Saccharomyces boulardii CNCM I-745
Ata: Mode of action of Saccharomyces boulardii CNCM I-745

Anotusi

Saccharomyces boulardii o le fefete. Sa faʻailoa muamua o se tasi ituaiga o fefete faʻapitoa. O lenei ua talitonuina o se ituaiga o Saccharomyces cerevisiae. Ae o le Saccharomyces boulardii e ese mai isi ituaiga o Saccharomyces cerevisiae e masani ona taʻua o le fefete a le fai meaʻai ma le mea fefete a le fai meaʻai. Saccharomyces boulardii e faʻaaogaina e fai ma vailaʻau.

Saccharomyces boulardii e masani ona faʻaaoga mo le togafitia ma le puipuia o le manava tata, e aofia ai ma ituaiga faʻamaʻi pipisi pei o le manava tata i tamaiti. E i ai ni faʻamaoniga o le faʻaaogaina mo isi ituaiga o manava tata, papala, ma se faʻamaʻi pipisi auala e mafai ona tau atu ai i papala.

Faʻamaʻi Coronavirus 2019 (COVID-19): E leai se faʻamaoniga lelei e lagolago ai le faʻaaogaina o Saccharomyces boulardii mo COVID-19. Mulimuli i filifiliga soifua maloloina soifua maloloina ma faʻataʻitaʻia le puipuia auala.

Natura Faʻafomaʻi Maea Faʻamatalaga fua faatatau aoga faʻavae i luga o faʻasaienitisi faʻamaoniga e tusa ma le fua faʻatatau lenei: Aoga, Masalo Lelei Lelei, E Lelei Lelei, Masalo Lelei Lelei, Masalo Lelei, Le Lelei, ma Le lava Faʻamaoniga e Fuafua ai.

Le aoga togi mo SACCHAROMYCES BOULARDII e faapea:


Masalo aoga mo ...

  • Manava tata. Ua faʻaalia mai i suʻesuʻega, o le tuʻuina atu o le Saccharomyces boulardii i tamaiti e maua i le manava tata e mafai ona faʻaititia ai le umi e oʻo atu i le 1 aso. Ae ole Saccharomyces boulardii e foliga mai e le aoga tele nai lo vailaʻau masani mo manava tata, pei ole loperamide (Imodium).
  • O le manava tata e mafua mai i le rotavirus. O le aveina o le Saccharomyces boulardii i pepe ma tamaiti e maua i le manava tata e mafua mai ile rotavirus e mafai ona faʻaititia ai le umi o le manava manava e tusa ma le 1 aso.

Masalo e aoga mo ...

  • Fuafua. Ua faʻaalia mai i suʻesuʻega le ave o le Saccharomyces boulardii e le gutu e faʻaleleia atili ai foliga o fuafua.
  • O le manava tatā i tagata o loʻo inu vailaʻau faʻafomaʻi (antibiotic-associate diarrhea). Ole tele o suʻesuʻega faʻaalia ai ole Saccharomyces boulardii e mafai ona fesoasoani e puipuia le manava tatā i tagata matutua ma tamaiti o loʻo togafitia ile vailaʻau. Mo 913 tagata mamaʻi uma na togafitia ma Saccharomyces boulardii i le taimi e togafitia ai ma vailaʻau faʻamaʻi, e toʻaitiiti le tagata e maua i le manava tata o le antibiotic.
  • Siama o le gastrointestinal tract e siama valaʻauina Clostridium difficile. Avea Saccharomyces boulardii faʻatasi ai ma vailaʻau faʻafomaʻi foliga mai e fesoasoani e puipuia Clostridium difficile-fesootai manava tata mai le toe tupu i tagata ma se talafaasolopito o le toe tupu. Avea Saccharomyces boulardii faʻatasi ai ma vailaʻau faʻafomaʻi foliga mai e fesoasoani e puipuia muamua vaega o Clostridium difficile-fesootai manava tatā. Ae le fautuaina e le au atamamai le faʻaaogaina o Saccharomyces mo le puipuia muamua o vaega.
  • O faʻamaʻi pipisi o meaʻai e mafai ona taitai atu ai i papala (Helicobacter pylori poʻo le H. pylori). Avea Saccharomyces boulardii ile gutu faʻatasi ai ma togafitiga masani H. pylori e fesoasoani e togafitia ai lenei faʻamaʻi. E tusa ma le 12 tagata e manaʻomia e togafitia ma faʻaopopo Saccharomyces boulardii mo le tasi tagata maʻi o le a tumau faʻamaʻi pipisi ina ia faʻamaloloina. Avea Saccharomyces boulardii e fesoasoani foi e puipuia le itu faʻataʻitaʻi e pei o le manava tata ma le niniva o loʻo tupu ma togafitiga masani H. pylori. Atonu e fesoasoani lenei mea i tagata e faʻauma a latou togafitiga masani mo H. pylori.
  • Tatala i tagata e maua i le HIV / AIDS. Avea Saccharomyces boulardii ile gutu e foliga mai e faʻaititia ai le manava tata e fesoʻotaʻi ma le HIV.
  • O se faʻamaʻi oona i totonu o pepe pepe vave (nekrotizing enterocolitis poʻo le NEC). O le tele o suʻesuʻega o loʻo faʻaalia ai o le tuʻuina atu o Saccharomyces boulardii i pepe laiti e puipuia ai le NEC.
  • Malu o le tagata malaga. Avea Saccharomyces boulardii e le gutu foliga mai e puipuia ai tagata femalagaaʻi 'manava.

Masalo le aoga mo ...

  • Toto pipisi (sepsis). Ua faʻaalia mai i suʻesuʻega, o le tuʻuina atu o Saccharomyces boulardii i tama meamea, e le mafai ona taofia ai le tipi.

Le lava molimau e fuaina aoga mo ...

  • O se faʻamaʻi o le manava e mafua ai manava tata (cholera). Saccharomyces boulardii e foliga mai e le faʻaleleia atili faʻamaʻi cholera, e tusa lava pe a tuʻuina atu i togafitiga masani.
  • Manatua ma mafaufauga mafaufauga (mafaufau faʻatino galuega). O suʻesuʻega amata e faʻaalia ai o le avea o le Saccharomyces boulardii e le fesoasoani i tamaiti aʻoga ia lelei atili i suʻega pe faʻaititia ai foʻi le mafatiaga.
  • O se ituaiga o faʻamaʻi manava manava (Crohn faʻamaʻi). Avea Saccharomyces boulardii e foliga mai e faʻaititia ai le aofaʻi o galu o gaioiga i tagata e maua i faʻamaʻi Crohn. O loʻo faʻaalia mai foi i le suʻesuʻeina, o le avea o le Saccharomyces boulardii ma le mesalamine e mafai ona fesoasoani ai i tagata e maua i le maʻi Crohn, e nonofo umi ai. Ae o le avea na o Saccharomyces boulardii na o ia e foliga mai e le fesoasoani i tagata e maua i faʻamaʻi Crohn tumau i le faʻamagaloina umi.
  • Fibrosis o le cystic. I le amataga o suʻesuʻega o loʻo faʻaalia ai o le avea o le Saccharomyces boulardii e le gutu e le faʻaitiitia ai faʻamaʻi fefete i le manava o meaʻai o loʻo i ai le cystic fibrosis.
  • Le lava le fatu. I le amataga o suʻesuʻega faʻaalia ai o le avea o le Saccharomyces boulardii e ono alualu ai i luma le fatu i tagata e faaletonu le fatu.
  • Kolisi maualuga. O suʻesuʻega muamua e faʻaalia ai ole Saccharomyces boulardii e foliga mai e le afaina le maualuga ole kolesterol.
  • O se faʻaletonu taimi o le lapoʻa tele e mafua ai le manava tiga (itaitagofie bowel poʻo IBS). Ua faʻaalia mai i suʻesuʻega le faʻamalieina o le olaga o tagata i le Saccharomyces boulardii i tagata e maua i le manava tata poʻo le fefiloi ituaiga IBS. Ae ole Saccharomyces boulardii e foliga mai e le faʻaleleia atili le tele o faʻailoga a le IBS pei o le manava tiga, faʻanatinati, poʻo le fula.
  • Faʻamaʻi o le manava e papala. I le amataga o suʻesuʻega o loʻo faʻaalia ai o le avea o le Saccharomyces boulardii e le gutu faʻatasi ma vailaʻau faʻafomaʻi e faʻaititia ai le manava tata ma tiga o le manava i tagata e maua i faʻamaʻi amoeba.
  • Lanu samasama o le paʻu i pepe (jaundice pepe). O ni pepe ua atiaʻe jaundice pe a maeʻa ona o le maualuga o le bilirubin. Avea Saccharomyces boulardii i pepe pepe ono taofia jaundice ma faʻaititia le manaʻoga mo phototherapy i se toʻaitiiti o nei pepe. Ae leiloa pe a fai o Saccharomyces boulardii e faʻaititia ai le aʻafia o jaundice i pepe e ono aʻafia. Avea Saccharomyces boulardii i pepe faʻatasi ai ma le phototherapy e le tuʻuina i lalo bilirubin maualuga sili atu nai lo phototherapy naʻo.
  • Tamaiti fananau mai e mamafa i lalo ole 2500 kalama (5 pauna, 8 aunese). Avea o se Saccharomyces boulardii faʻaopopoga pe a uma le fanau mai e foliga mai e faʻaleleia ai le mauaina o le mamafa mauaina ma fafagaina i pepe matutua ma maualalo mamafa mamafa.
  • Ova tele le tutupu o siama i totonu o tamaʻi manava. I le amataga o suʻesuʻega o loʻo faʻaalia ai o le faʻaopopoina o Saccharomyces boulardii i togafitiga ma vailaʻau faʻamalosi tino e faʻaititia ai le faʻatupuina o siama i totonu o le manava e sili atu i lo naʻo vailaʻau.
  • O se ituaiga o faʻamaʻi manava manava (ulcerative colitis). I le amataga o suʻesuʻega o loʻo faʻaalia ai o le faʻaopopoina o Saccharomyces boulardii i le faʻamasaniina o le mesalamine togafitiga e mafai ona faʻaititia ai faʻailoga i tagata e maua i le maʻi palu faʻapipiʻi.
  • Canker poʻu.
  • Fiva feula.
  • Hives.
  • Lactose le faapalepale.
  • Faamaʻi Lyme.
  • O tiga o maso e mafua mai i le faamalositino.
  • Faʻamaʻi pipisi o le urinary tract (UTIs).
  • Faʻamaʻi fefete.
  • Isi tulaga.
E tele faʻamaoniga e manaʻomia e fua ai Saccharomyces boulardii mo nei faʻaaogaina.

Saccharomyces boulardii e taʻua o le "probiotic," o se meaola faʻauo e fesoasoani e teteʻe ese ai faʻamaʻi e mafua ai faʻamaʻi i le manava e pei o siama ma fefete.

A ave e le gutu: Saccharomyces boulardii o MAFAI ONA SAFIA mo le tele o tagata matutua pe a ave e le gutu e oʻo atu i le 15 masina. E mafai ona mafua ai kesi i nisi tagata. E seasea, ono mafua ai faʻamaʻi pipisi e mafai ona sosolo i totonu o le toto i le tino atoa (fungemia).

Lapataiga faʻapitoa & lapataʻiga:

Maitaga ma susu-fafagaina: E le lava faʻamatalaga faʻatuatuaina e iloa ai pe a fai o le Saccharomyces boulardii e saogalemu e faʻaaoga pe a maʻito pe fafagaina susu. Tumau i le itu saogalemu ma aloese mai le faʻaaogaina.

Tamaiti: Saccharomyces boulardii o MAFAI ONA SAFIA mo tamaiti pe a fai e le gutu talafeagai. Peitai, manava tatā i tamaiti e tatau ona iloiloina e se fomaʻi polofesa i luma o le faʻaaogaina Saccharomyces boulardii.

Matua: Tagata matutua ono i ai se faʻaopopoga ono aʻafia o siama inifeti pe a inu Saccharomyces boulardii. Tumau i le itu saogalemu ma aloese mai le faʻaaogaina.

Faʻavaivaia faiga puipuia: E i ai le popolega o le avea Saccharomyces boulardii ono mafua ai fungemia, o le i ai lea o le fefete i le toto. Ole numera moni o mataupu ole Saccharomyces boulardii-related fungemia e faigata ona mautinoa. Peitaʻi, o le aʻafiaga e foliga mai e sili atu mo tagata o loʻo mamaʻi tele poʻo ua vaivai vaivaiga puipuia. Faʻapitoa lava, tagata ma catheters, i latou o loʻo mauaina paipa fafagaina, ma i latou o loʻo togafitia i le tele o vailaʻau ma vailaʻau oona e galulue i le tele o ituaiga o faʻamaʻi foliga mai e sili ona lamatia. I le tele o tulaga, o le fungemia na mafua mai i le faʻaleagaina o le catheter e le ea, luga o le siʻosiʻomaga, poʻo lima na faʻaleagaina i Saccharomyces boulardii.

Le afaina o le fefete: Tagata e iai faʻamaʻi fefete e mafai ona afaina i mea o loʻo iai Saccharomyces boulardii, ma e fautuaina lelei oe e aloese mai nei oloa.

Laititi
Ia mataala i lenei tuʻufaʻatasiga.
Vailaau mo siama fiva (Antifungals)
Saccharomyces boulardii o lefua. O vailaʻau mo faʻamaʻi fula e fesoasoani e faʻaititia ai le fungus i totonu ma luga o le tino. O le inuina o le Saccharomyces boulardii ma vailaʻau mo faʻamaʻi iniseti e mafai ona faʻaititia ai le aoga ole Saccharomyces boulardii.
O nisi vailaʻau mo siama fungal aofia fluconazole (Diflucan), caspofungin (Cancidas), itraconazole (Sporanox) amphotericin (Ambisome), ma isi.
E leai ni fesoʻotaʻiga lauiloa ma laʻau ma mea faʻaopopo.
E leai ni fesoʻotaʻiga iloa ma meaʻai.
O vailaʻau nei sa suʻesuʻeina i suʻesuʻega faasaienisi.

MATUTUA

E LE SAU:
  • Mo manava tatā i tagata o loʻo ave ni vailaʻau (vailaʻau faʻafesoʻotaʻi vailaʻau): 250-500 mg o Saccharomyces boulardii aveina 2-4 taimi i aso uma e oʻo atu i le 2 vaiaso e masani ona faʻaaogaina. I le tele o tulaga, o tui i aso uma e le sili atu i le 1000 mg i aso uma.
  • Mo faʻamaʻi o le gastrointestinal tract e siama e taʻua o le Clostridium difficile: Mo le puipuia o le toe tupu, 500 mg o Saccharomyces boulardii faʻalua i aso uma mo le 4 vaiaso faʻatasi ai ma vailaʻau vailaʻau.
  • Mo se faʻamaʻi pipisi auala e mafai ona taitai atu ai i papala (Helicobacter pylori poʻo H. pylori): 500-1000 mg o Saccharomyces boulardii i aso uma mo 1-4 vaiaso e masani ona faʻaaogaina.
  • Mo manava tata i tagata e maua i le HIV / AIDS: 3 kalama o Saccharomyces boulardii i aso uma.
  • Mo tagata femalagaaʻi 'manava tata: 250-1000 mg o Saccharomyces boulardii i aso uma mo le 1 masina.
FANAU

E LE SAU:
  • Mo manava tatā i tagata o loʻo ave ni vailaʻau (vailaʻau faʻafesoʻotaʻi vailaʻau): 250 mg o Saccharomyces boulardii tasi pe faʻalua i aso uma mo le umi o fualaʻau na faʻaogaina.
  • Mo manava tata: Mo le togafitia o le manava tata, 250 mg o Saccharomyces boulardii tasi pe faʻalua i aso uma pe 10 piliona piliona-fausia iunite tasi taimi i aso uma mo 5 aso na faʻaaogaina. Mo le togafitia o le manava manava, 1750 piliona i le 175 triliona kolone-fausia iunite o Saccharomyces boulardii faalua i aso uma mo 5 aso na faʻaaogaina. Mo le puipuia o le manava tata i tagata o loʻo mauaina ni fafagaina paipa, 500 mg o Saccharomyces boulardii faʻafa i aso uma na faʻaaogaina.
  • Mo manava tata mafua mai rotavirus: 200-250 mg o Saccharomyces boulardii faʻalua i aso uma mo le 5 aso na faʻaaogaina.
  • Mo se faʻamaʻi oona i totonu o pepe pepe vave (nekrotizing enterocolitis po o le NEC): 100-200 mg / kg Saccharomyces boulardii i aso uma, amata ile vaiaso muamua talu ona fanau.
Probiotic, Probiotique, Saccharomyces, Saccharomyces Boulardii CNCM I-745, Saccharomyces Boulardii HANSEN CBS 5926, Saccharomyces Boulardii Lyo CNCM I-745, Saccharomyces Boulardius, Saccharomyces Cerevisiae Boulardii, Saccharomyces Cerevisiaeia (Boulevard Cerevisiaeia Cerevisiae HANSEN CBS 5926, Saccharomyces cerevisiae var boulardii, S. Boulardii, SCB.

Ina ia aoao atili e uiga i le auala na tusia ai lenei tusitusiga, faʻamolemole vaʻai i le Natura Faʻafomaʻi Maea Faʻamatalaga metotia


  1. Florez ID, Veroniki AA, Al Khalifah R, et al. Faʻatusatusaga aoga ma le saogalemu o faʻalavelave mo le manava tatā ma gastroenteritis i tamaiti: O se faʻavasega iloiloga ma fesoʻotaʻiga meta-auiliiliga. PLoS Tasi. 2018; 13: e0207701. Vaʻai faʻamatala.
  2. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. O le faʻaopopoga o le Probiotic e faʻaosofia ai suiga lelei i le tiga o musele ma le lelei o le moe o tagata lakapi. J Sci Med Taʻaloga. 2020: S1440-244030737-4. Vaʻai faʻamatala.
  3. Gao X, Wang Y, Shi L, Feng W, Yi K. Aafiaga ma le saogalemu o Saccharomyces boulardii mo neonatal necrotizing enterocolitis i pepe muamua: O se iloiloga faʻavasega ma meta-auiliiliga. J Trop Pediatr. 2020: fmaa022. Vaʻai faʻamatala.
  4. Mourey F, Sureja V, Kheni D, et al. O le multicenter, randomized, lua-blind, placebo-pulea faʻataʻitaʻiga o Saccharomyces boulardii i pepe ma tamaiti e ogaoga le manava tata. Pediatr Infect Dis J. 2020; 39: e347-e351. Vaʻai faʻamatala.
  5. Karbownik MS, Kr & eogon; czy & nacute; ska J, Kwarta P, et al. Aʻafiaga o le faʻaopopoga ma Saccharomyces boulardii luga o aʻoaʻoga suʻesuʻega gaioiga ma fesoʻotaʻiga popole i soifua maloloina tamaiti aʻoga: O se randomized, faalua-tauaso, placebo-pulea faʻataʻitaʻiga. Meaʻai. 2020; 12: 1469. Vaʻai faʻamatala.
  6. Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii o se fesoasoani faʻaopoopo mo le Helicobacter pylori faʻamamaina: O se faʻavasega iloiloga ma meta-auiliiliina ma faʻataʻitaʻiga faʻasolosolo auiliiliga. Helicobacter. 2019; 24: e12651. Vaʻai faʻamatala.
  7. Szajewska H, ​​Kolodziej M, Zalewski BM. Iloiloga faʻasolosolo ma meta-auiliiliga: Saccharomyces boulardii mo le togafitia o gastroenteritis matuitui i tamaiti-o le 2020 faʻafouga. Aliment Pharmacol Ther. 2020. Vaʻai faʻamatala.
  8. Seddik H, Boutallaka H, ​​Elkoti I, et al. Saccharomyces boulardii CNCM I-745 ma faʻasolosolo togafitiga mo Helicobacter pylori faʻamaʻi: o se randomized, tatala-igoa faʻamasinoga. Eur J Clin Pharmacol. 2019; 75: 639-645. Vaʻai faʻamatala.
  9. García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, et al. Le aoga o le Saccharomyces boulardii ma le Metronidazole mo Laʻititi Iva Iama Iva ile Faʻamaʻi ole Systemic Sclerosis. 2019. Vaʻai faʻamatala.
  10. McDonald LC, Gerding DN, Johnson S, et al. Faʻamaʻi pipisi sosaiete o Amerika. Taʻiala faʻataʻitaʻi faʻapitoa mo Clostridium difficile siama i tagata matutua ma tamaiti: 2017 faʻafouina e le Infectious Diseases Society of America (IDSA) ma le Sosaiete a le Soifua Maloloina Epidemiology o Amerika (SHEA). Faamaʻi pipisi Falemai 2018; 66: e1-e48.
  11. Xu L, Wang Y, Wang Y, et al. O le faʻalua-tauaso faʻataʻitaʻiina faʻataʻitaʻiina i le tuputupu aʻe ma fafagaina faʻapalepale ma Saccharomyces boulardii CNCM I-745 i fua-fafagaina pepe matutua. J Pediatr (Rio J). 2016; 92: 296-301. Vaʻai faʻamatala.
  12. Sheele J, Cartowski J, Dart A, et al. Saccharomyces boulardii ma bismuth subsalicylate o ni mea taugofie e faʻaititia ai le umi ma le faigata o le kolela. Pathog Glob Soifua Maloloina. 2015; 109: 275-82. Vaʻai faʻamatala.
  13. Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Aafiaga o le Probiotic Saccharomyces boulardii i Cholesterol ma Lipoprotein Particles i Hypercholesterolemic Matutua: O Nofofua-Lima, Tatala-Label Pilot Suesuega. J Suʻesuʻega Faʻapitoa Med. 2015; 21: 288-93. Vaʻai faʻamatala.
  14. Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii mo le puipuia o le falemai onset Clostridium difficile siama. J Gastrointestin ate Dis. 2015; 24: 21-4. Vaʻai faʻamatala.
  15. Ehrhardt S, Guo N, Hinz R, et al. Saccharomyces boulardii e Puipuia le Manava o le Antibiotic-Associated: O Se Faʻataʻitaʻiga, Faʻalua-Ufiufi, Faʻataʻitaʻiga Pulea i le Placebo. Tatala Forum Infect Dis. 2016; 3: ofw011. Vaʻai faʻamatala.
  16. Dinleyici EC, Kara A, Dalgic N, et al. Saccharomyces boulardii CNCM I-745 faʻaititia le umi o le manava tata, umi ole faʻalavelave faʻafuaseʻi ma le falemaʻi nofo i tamaiti e maua i le manava tata. Faʻamanuiaga Microbes. 2015; 6: 415-21. Vaʻai faʻamatala.
  17. Dauby N. Faʻalavelave o Saccharomyces boulardii-O loʻo iai Probiotics mo le Puipuia o Clostridium difficile siama i le Matua. Gastroenterology. 2017; 153: 1450-1451. Vaʻai faʻamatala.
  18. Cottrell J, Koenig K, Perfekt R, Hofmann R; Loperamide-Simethrylic Ogaoga Diarrhea Suesuega Vaega. Faʻatusatusaga o Lua Ituaiga o Loperamide-Simethicone ma le Probiotic Yeast (Saccharomyces boulardii) i le Togafitiga o le Matuitui Manava i Tagata Matutua: O Se Faʻataʻitaʻi Lelei Faʻataʻitaʻi E Le-Le Maulalo Lelei. Fualaʻau R D. 2015; 15: 363-73. Vaʻai faʻamatala.
  19. Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Probiotic togafitiga ma Saccharomyces boulardii mo tagata mama fatu fatu: o se randomized, lua-tauaso, placebo-pulea pailate faamasinoga. Int J Cardiol. 2015; 179: 348-50. Vaʻai faʻamatala.
  20. Carstensen JW, Chehri M, Schønning K, et al. Faʻaaogaina o prophylactic Saccharomyces boulardii e puipuia ai faʻamaʻi pipisi Clostridium i tagata mamaʻi i falemaʻi: o se faʻatonutonu vaʻaia vaʻavaʻaia faʻatonutonu suʻesuʻega. Eur J Clin Microbiol Infect Dis. 2018; 37: 1431-1439. Vaʻai faʻamatala.
  21. Asmat S, Shaukat F, Asmat R, Bakhat HFSG, Asmat TM. Fuafua Lelei Faʻatusatusaga o Saccharomyces Boulardii ma Lactic Acid o Probiotics i Tui Pediatric manava tata. J Coll Fomaʻi Surg Pak. 2018; 28: 214-217. Vaʻai faʻamatala.
  22. Remenova T, Morand O, Amato D, Chadha-Boreham H, Tsurutani S, Marquardt T. O le faʻalua-tauaso, faʻasolosolo, placebo-pulea faʻataʻitaʻiga suʻesuʻeina o aʻafiaga o Saccharomyces boulardii i luga ole gastrointestinal tolerability, saogalemu, ma vailaʻau mo togafitiga o miglustat. Orphanet J Rare Dis 2015; 10: 81. Vaʻai faʻamatala.
  23. Suganthi V, Das AG. Matafaioi o Saccharomyces boulardii i le faʻaititia o le neonatal hyperbilirubinemia. J Clin Diagn Res 2016; 10: SC12-SC15. Vaʻai faʻamatala.
  24. Riaz M, Alam S, Malik A, Ali SM. Malosiaga ma le saogalemu o Saccharomyces boulardii i matuitui tamaiti manava manava: o le faalua tauaso randomized pulea faamasinoga. Initia J Pediatr 2012; 79: 478-82. Vaʻai faʻamatala.
  25. - Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Togafitiga o le manava tatā ma Saccharomyces boulardii i pepe. J Pediatr Gastroenterol Nutr 2011; 53: 497-501. Vaʻai faʻamatala.
  26. Cohen SH, Gerding DN, Johnson S, et al. Sosaiete mo le Soifua Maloloina Epidemiology o Amerika; Faʻamaʻi pipisi sosaiete o Amerika. Taʻiala faʻataʻitaʻi faʻapitoa mo Clostridium difficile siama i tagata matutua: 2010 faʻaleleia e le sosaiete mo le soifua maloloina epidemiology o Amerika (SHEA) ma faʻamaʻi pipisi sosaiete o Amerika (IDSA). Iniseti Pulea Hosp Epidemiol 2010; 31: 431-55. Vaʻai faʻamatala.
  27. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics mo le puipuia o Clostridium difficile-fesootai manava tata i tagata matutua ma tamaiti. Cochrane Database Syst Rev. 2013;: CD006095. Vaʻai faʻamatala.
  28. Lau CS, Chamberlain RS. Probiotics e aoga i le puipuia Clostridium difficile-fesoʻotaʻi manava: o se faʻavasega iloiloga ma meta-auiliiliga. Int J Gen Med. 2016; 9: 27-37. Vaʻai faʻamatala.
  29. Roy U, Jessani LG, Rudramurthy SM, et al. Fitu mataupu o Saccharomyces fungaemia fesoʻotaʻi ma le faʻaaogaina o probiotics. Mycoses 2017; 60: 375-380. Vaʻai faʻamatala.
  30. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia i se tamaiti gasegase pe a uma togafitiga ma probiotics. Rev Paul Pediatr 2017; 35: 361-4. Vaʻai faʻamatala.
  31. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii mo le puipuia o le manava faʻafuaseʻi e fesoʻotaʻi ma tagata matutua i le falemaʻi gasegase: o le tasi-ogatotonu, faʻasolosolo, faʻalua-tauaso, faʻataʻitaʻiga nofoaga. Am J Gastroenterol 2012; 107: 922-31. Vaʻai faʻamatala.
  32. Martin IW, Tonner R, Trivedi J, et al. Saccharomyces boulardii probiotic-fesootai fungemia: fesiligia le saogalemu o lenei puipuia probiotic's faaaogaina. Diagn Microbiol Infect Dis. 2017; 87: 286-8. Vaʻai faʻamatala.
  33. Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. O se faʻasolosolo, faʻalua-tauaso, placebo-pulea multicenter faʻataʻitaʻiga o Saccharomyces boulardii i itaitagofie bowel syndrome: aafiaga i le lelei o le olaga. J Clin Gastroenterol. 2011; 45: 679-83. Vaʻai faʻamatala.
  34. Atici S, Soysal A, Karadeniz Cerit K, et al. Catheter-related Saccharomyces cerevisiae Fungemia Ina ua maeʻa Saccharomyces boulardii Probiotic Togafitiga: I se tamaititi i potu ogaoga tausiga ma iloiloina o tusitusiga. Med Mycol Case Rep. 2017; 15: 33-35. Vaʻai faʻamatala.
  35. Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia mulimuli i togafitiga faʻataʻitaʻi. Med Mycol Case Rep. 2017; 18: 15-7. Vaʻai faʻamatala.
  36. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Ole tele o ituaiga probiotics foliga mai o le sili atu aoga probiotics i le puipuia o le necrotizing enterocolitis ma le olaga nei: O se toe faʻaleleia meta-auiliiliga. PLoS Tasi. 2017; 12: e0171579. Vaʻai faʻamatala.
  37. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics mo le Puipuia o le Manava o le Antibiotic-Associated i Outpatients-O le Iloiloina ma le Meta-Suʻesuʻega. Antibiotics (Basel). 2017; 6. Vaʻai faʻamatala.
  38. Al Faleh K, Anabrees J. Probiotics mo le puipuia o le necrotizing enterocolitis i pepe laiti. Cochrane Database Syst Rev. 2014;: CD005496. Vaʻai faʻamatala.
  39. Das S, Gupta PK, Das RR. Malosiaga ma le Saogalēmū o Saccharomyces boulardii i le Maʻi o le Rotavirus Diarrhea: Faʻalua Tauaso Faʻataʻitaʻi Faʻataʻitaʻiina Faʻataʻitaʻiga mai se Atinaʻe Atunuʻu. J Trop Pediatr. 2016; 62: 464-470. Vaʻai faʻamatala.
  40. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics mo le puipuia ole tamaititi vailaʻau faʻafomaʻi o le manava tata. Cochrane Database Syst Rev. 2015;: CD004827. Vaʻai faʻamatala.
  41. Feizizadeh S, Salehi-Abargouei A, Akbari V. Malosiaga ma le saogalemu o Saccharomyces boulardii mo matuitui o le manava tata. Pediatrics. 2014; 134: e176-191. Vaʻai faʻamatala.
  42. Szajewska H, ​​Horvath A, Kolodziej M. Faʻatulagaina iloiloga ma meta-auiliiliga: Saccharomyces boulardii faʻaopoopoga ma le faʻamamaina o Helicobacter pylori siama. Aliment Pharmacol Ther. 2015; 41: 1237-1245. Vaʻai faʻamatala.
  43. Szajewska H, ​​Kolodziej M. Faʻamatalaga faʻasolosolo ma meta-auiliiliga: Saccharomyces boulardii i le puipuia o vailaʻau faʻafuaseʻi --a faʻamaʻi le manava tatā. Aliment Pharmacol Ther. 2015; 42: 793-801. Vaʻai faʻamatala.
  44. Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic tei ona o Sacccaromyces boulardii. Med Mal pipisi. 2016; 46: 104-105. Vaʻai faʻamatala.
  45. Bafutto M, et al. Togafitiga o le manava tataa-sili ona afaina ai bowel syndrome ma mesalamine ma / po o Saccharomyces boulardii. Arq Gastroenterol. 2013; 50: 304-309. Vaʻai faʻamatala.
  46. Bourreille A, et al. Saccharomyces boulardii e le taofia le toe oso o le faʻamaʻi o Crohn. Clin Gastroenterol Hepatol. 2013; 11: 982-987.
  47. Serce O, Gursoy T, Ovali F, Karatekin G. Aafiaga o Saccaromyces boulardii i le neonatal hyperbilirubinemia: o se faʻatonutonuina faʻatonutonuina faʻataʻitaʻiga. Am J Perinatol. 2015; 30: 137-142. Vaʻai faʻamatala.
  48. Videlock EJ, Cremonini F. Meta-auiliiliga: probiotics i vailaʻau-fesoʻotaʻi manava tata. Aliment Pharmacol Ther. 2012; 35: 1355-69. Vaʻai faʻamatala.
  49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics mo le puipuia ma le togafitia o fualaʻau e fesoʻotaʻi ma le manava tata: o se faʻavasega iloiloga ma meta-auiliiliga. IAMA. 2012 9; 307: 1959-69. Vaʻai faʻamatala.
  50. Elmer GW, Moyer KA, Vega R, ma et al. Suʻesuʻega o Saccharomyces boulardii mo tagata mamaʻi e maua i le HIV e manaʻomia faʻaletonu ma i tagata soifua maloloina o loʻo mauaina ni antifungals. Microecology Ther 1995; 25: 23-31.
  51. Potts L, Lewis SJ, ma Barry R. Faʻataʻitaʻiina faʻalua taʻutaʻua placebo faʻatonutonu suʻesuʻega o le agavaʻa o Saccharomyces boulardii e puipuia ai fualaʻau faʻafitauli o le manava tatalaina Gut 1996; 38 (supa 1): A61.
  52. Bleichner G ma Blehaut H. Saccharomyces boulardii puipuia le manava tatā i tagata mamaʻi gasegase fafagaina gasegase. O se multicenter, faʻasolosolo, faʻalua-tauaso placebo-pulea faʻataʻitaʻiga [abstract]. Clin Nutr 1994; 13 Suppl 1:10.
  53. Maupas JL, Champemont P, ma Delforge M. [Togafitiga o le itaitagofie o le manava manava ma Saccharomyces boulardii - o se lua-tauaso, placebo pulea suesuega]. Médisin et Chirurgie Digestives 1983; 12: 77-79.
  54. Saint-Marc T, Blehaut H, Musial C, ma et al. [O le manava e fesoʻotaʻi ma le AIDS: o le faʻataʻitaʻiina o le Saccharomyces boulardii]. Semaine Des Hopitaux 1995; 71 (23-24): 735-741.
  55. McFarland LV, Surawicz C, Greenberg R, ma et al. Saccharomyces boulardii ma maualuga inumaga vancomycin togafitia faʻasolosolo Clostridium difficile faʻamaʻi [abstract]. Am J Gastroenterol 1998; 93: 1694.
  56. Chouraqui JP, Dietsch J, Musial C, ma et al. Saccharomyces boulardii (SB) i le puleaina o le manava o tamaiti: o se lua-blind-placebo pulea faʻataʻitaʻiga [abstract]. J Pediatr Gastroenterol Nutr 1995; 20: 463.
  57. Cetina-Sauri G ma Basto GS. Evaluacion terapeutica de Saccharomyces boulardii en ninos con diarrea aguda. Tribuna Med 1989; 56: 111-115.
  58. Adam J, Barret C, Barret-Bellet A, ma et al. Essais cliniques controles en lua insu de lʻUltra-Levure Lyophilisee. Etude multicentrique par 25 medecins de 388 cas. Gaz Med Fr 1977; 84: 2072-2078.
  59. McFarland LV, SurawiczCM, Elmer GW, ma et al. Multivariate auiliiliga o le aoga aoga o se biotherapeutic sui sooupu, Saccharomyces boulardii mo le puipuia o vailaʻau-fesoʻotaʻi manava tata (abstract]. Am J Epidemiol 1993; 138: 649.
  60. Saint-Marc T, Rossello-Prats L, ma Touraine JL. [Le aoga ole Saccharomyces boulardii ile puleaina ole papala ole AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65.
  61. Kirchhelle, A., Fruhwein, N., ma Toburen, D. [Togafitiga o le manava manava ma S. boulardii i tagata toe foʻi mai. Faʻaiuga o se suʻesuʻega faamoemoeina]. Fortschr Med 4-20-1996; 114: 136-140. Vaʻai faʻamatala.
  62. Fanau, P., Lersch, C., Zimmerhackl, B., ma Classen, M. [Le Saccharomyces boulardii togafitiga o le manava tata e aafia ai le HIV]. Dtsch Med Wochenschr 5-21-1993; 118: 765. Vaʻai faʻamatala.
  63. Kollaritsch, H., Holst, H., Grobara, P., ma Wiedermann, G. [Puipuia le manava o le tagata malaga ma Saccharomyces boulardii. Faʻaiuga o le placebo pulea faʻalua-tauaso suesuega]. Fortschr.Med 3-30-1993; 111: 152-156. Vaʻai faʻamatala.
  64. Tempe, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., ma Maurier, F. [Puipuia le manava tatalaina Saccharomyces boulardii i le taimi o fafagaina faifaipea]. Sem. Afi. 5-5-1983; 59: 1409-1412. Vaʻai faʻamatala.
  65. Chapoy, P. [Togafitiga o le manava manava manava o le pepe: faʻatonutonuina faʻataʻitaʻiga o Saccharomyces boulardii]. Ann Pediatr. (Paris) 1985; 32: 561-563. Vaʻai faʻamatala.
  66. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., ma McFarland, L. V. Puipuia le toe tupu o Clostridium difficile colitis ma Saccharomyces boulardii. Dig.Dis Sci 1990; 35: 897-901. Vaʻai faʻamatala.
  67. Saint-Marc, T., Rossello-Prats, L., ma Touraine, J. L. [Le aoga o Saccharomyces boulardii i le togafitia o le manava tata i le AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65. Vaʻai faʻamatala.
  68. Duman, DG, Bor, S., Ozutemiz, O., Sahin, T., Oguz, D., Unfollow, F., Vural, T., Sandkci, M., Isksal, F., Simsek, I., Soyturk , M., Arslan, S., Sivri, B., Soykan, I., Temizkan, A., Bessk, F., Kaymakoglu, S., ma Kalayc, C. Malosiaga ma le saogalemu o Saccharomyces boulardii i le puipuia o vailaʻau faʻafomaʻi - faʻapipiʻi fesoʻotaʻi ona o le Helicobacterpylori faʻaumatia. Eur J Gastroenterol.Hepatol. 2005; 17: 1357-1361. Vaʻai faʻamatala.
  69. Surawicz, C. M. Togafitiga o le toe tupu Clostridium difficile-fesoʻotaʻi maʻi. Nat Clin Practice. Gastroenterol. Hepatol. 2004; 1: 32-38. Vaʻai faʻamatala.
  70. Kurugol, Z. ma Koturoglu, G. Aʻafiaga o Saccharomyces boulardii i tamaiti e maua i le manava tata. Acta Paediatr. 2005; 94: 44-47. Vaʻai faʻamatala.
  71. Kotowska, M., Albrecht, P., ma Szajewska, H. Saccharomyces boulardii i le puipuia o le manava tata e fesoʻotaʻi ma vailaʻau faʻamalositino i tamaiti: o se faʻataʻitaʻiga o le faʻataʻitaʻiga o le faʻataʻotoina o nofoaga e faʻaluaina le faʻataʻotoina. Aliment.Fharmacol.Ther. 3-1-2005; 21: 583-590. Vaʻai faʻamatala.
  72. Cherifi, S., Robberecht, J., ma Miendje, Y. Saccharomyces cerevisiae fungemia i se tagata matua onosai ma Clostridium difficile colitis. Acta Clin Belg. 2004; 59: 223-224. Vaʻai faʻamatala.
  73. Erdeve, O., Tiras, U., ma Dallar, Y. O le probiotic aafiaga o Saccharomyces boulardii i le pediatric tausaga tausaga. J Trop.Pediatr. 2004; 50: 234-236. Vaʻai faʻamatala.
  74. Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., ma Petrochilou, V. Faʻatagaina ulufale o pepe laiti ma Saccharomyces boulardii. Early Hum.Dev. 2003; 74: 89-96. Vaʻai faʻamatala.
  75. Gaon, D., Garcia, H., Winter, L., Rodriguez, N., Quintas, R., Gonzalez, S. N., ma Oliver, G. Aafiaga o Lactobacillus faigata ma Saccharomyces boulardii i le manava manava tatamaiti i tamaiti. Medicina (B Aires) 2003; 63: 293-298. Vaʻai faʻamatala.
  76. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., ma Shafaghi, A. O le aoga o saccharomyces boulardii ma vailaʻau faʻafofuina i le amoebiasis. Lalolagi J Gastroenterol. 2003; 9: 1832-1833. Vaʻai faʻamatala.
  77. Riquelme, A. J., Calvo, M. A., Guzman, A.M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., ma Labarca, J. A. Saccharomyces cerevisiae fungemia ina ua maeʻa le Saccharomyces boulardii togafitiga i tagata mamaʻi puipuia. J Clin.Gastroenterol. 2003; 36: 41-43. Vaʻai faʻamatala.
  78. Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, EC, Lupascu, A., Gasbarrini, G., ma Gasbarrini, A. Probiotics i vailaʻau-fesoʻotaʻi manava tata Dig.Liver Dis. 2002; 34 Faʻaopopo 2: S78-S80. Vaʻai faʻamatala.
  79. Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., ma Malbrunot, C. Fitu mataupu o le fungemia ma Saccharomyces boulardii i faitioga. tagata mamaʻi. Vaʻaia Fafo Med 2002; 28: 797-801. Vaʻai faʻamatala.
  80. Tasteyre, A., Barc, M. C., Karjalainen, T., Bourlioux, P., ma Collignon, A. Le taofiofia o le vitro cell adherence o Clostridium difficile e Saccharomyces boulardii. Poloi 2002; 32: 219-225. Vaʻai faʻamatala.
  81. Shanahan, F. Faʻamalositino i faʻamaʻi pipisi o le manava. Gut 2001; 48: 609. Vaʻai faʻamatala.
  82. Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M., Fekety, R., Mulligan, ME, Garcia, RJ, Brandmarker, S., Bowen, K., Borjal, D., ma Elmer, GW Le saili mo se togafitiga sili atu mo le toe tupu Clostridium difficile faʻamaʻi: faʻaaogaina o le maualuga-inumaga vancomycin tuʻufaʻatasia ma Saccharomyces boulardii. Togafitiga. Faʻamama. 2000; 31: 1012-1017. Vaʻai faʻamatala.
  83. Johnston BC, Ma SSY, Goldenberg JZ, et al. Probiotics mo le puipuia o Clostridium difficile-fesootai manava tata. Ann Intern Med 2012; 157: 878-8. Vaʻai faʻamatala.
  84. Munoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: o se faʻamaʻi pipisi ua aliaʻe mai. Clin Infect Dis 2005; 40: 1625-34. Vaʻai faʻamatala.
  85. Szajewska H, ​​Mrukowicz J. Meta-auiliiliga: fefete le faʻafefeteina Saccharomyces boulardii i le puipuia o le manava tata e fesoʻotaʻi ma vailaʻau. Aliment Pharmacol Ther 2005; 22: 365-72. Vaʻai faʻamatala.
  86. Mafai M, Besirbellioglu BA, Avci IY, et al. Prophylactic Saccharomyces boulardii i le puipuia o le manava faʻafomaʻi e fesoʻotaʻi ma vailaʻau faʻafomaʻi: O se suʻesuʻega fuafuaina Med Sci Monit 2006; 12: PI19-22. Vaʻai faʻamatala.
  87. Guslandi M, Giollo P, Testoni PA. O se pailate faʻataʻitaʻi o Saccharomyces boulardii i le ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 697-8. Vaʻai faʻamatala.
  88. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii i le tausiga o togafitiga o Crohn's disease. Dig Dis Sci 2000; 45: 1462-4. Vaʻai faʻamatala.
  89. McFarland LV. Meta-auiliiliga o probiotics mo le puipuia o vailaʻau faʻafomaʻi fesoʻotaʻi ma le togafitiga o Clostridium difficile faʻamaʻi. Am J Gastroenterol 2006; 101: 812-22. Vaʻai faʻamatala.
  90. Marteau P, Seksik P. Faʻapalepaleina o faʻafitauli ma faʻataʻitaʻi. J Clin Gastroenterol 2004; 38: S67-9. Vaʻai faʻamatala.
  91. Borriello SP, Hammes WP, Holzapfel W, et al. Saogalēmū o faʻataʻitaʻiga o loʻo iai lactobacilli poʻo le bifidobacteria. Clin Infect Dis 2003; 36: 775-80. Vaʻai faʻamatala.
  92. Cremonini F, Di Caro S, Covino M, et al. Aʻafiaga o eseese probiotic sauniuniga on anti-helicobacter pylori togafitiga-fesoʻotaʻiga aʻafiaga: o se tutusa vaega, tolu faʻatauaso, placebo-pulea suesuega. Am J Gastroenterol 2002; 97: 2744-9. Vaʻai faʻamatala.
  93. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics i le puipuia o vailaʻau faʻafomaʻi e fesoʻotaʻi manava: meta-auiliiliga. BMJ 2002; 324: 1361. Vaʻai faʻamatala.
  94. Muller J, Remus N, Faʻafitauli KH. Suesuega ole mycoserological ole togafitia o tamaiti gasegase o le cystic fibrosis ma Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Mycoses 1995; 38: 119-23. Vaʻai faʻamatala.
  95. Plein K, Hotz J. Therapeutic effects o Saccharomyces boulardii i luga o ni nai toega o faʻailoga i se vaega mautu o le faʻamaʻi o Crohn ma le faʻaaloalo faapitoa lava i le manava tata - o se pailate suʻesuʻe. Z Gastroenterol 1993; 31: 129-34. Vaʻai faʻamatala.
  96. Hennequin C, Thierry A, Richard GF, et al. O le taina o le masini tipi faaleoleo a le satelatone e avea ma mea faigaluega fou mo le faʻailoaina o Saccharomyces cerevisiae ituaiga. J Clin Microbiol 2001; 39: 551-9. Vaʻai faʻamatala.
  97. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia i se neutropenic tagata gasegase togafitia ma Saccharomyces boulardii. Lagolago Care Kanesa 2000; 8: 504-5. Vaʻai faʻamatala.
  98. Weber G, Adamczyk A, Freytag S. [Togafitiga o fuafua ma se fefete sauniuniga]. Fortschr Med 1989; 107: 563-6. Vaʻai faʻamatala.
  99. Lewis SJ, Freedman AR. Tusitusiga toe iloilo: o le faʻaaogaina o vailaʻau o le biotherapeutic i le puipuia ma le togafitia o faʻamaʻi gastrointestinal. Aliment Pharmacol Ther 1998; 12: 807-22. Vaʻai faʻamatala.
  100. Krammer M, Karbach U. Antidiarrheal gaioiga o le fefete Saccharomyces boulardii i le isumu laititi ma lapoʻa ala i le faʻaosofia o le faʻaaogaina o le chloride. Z Gastroenterol 1993; 31: 73-7.
  101. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii e taofia ai le adagosine 3 ', 5'-cyclic monophosphate faʻatosinaina i sela sela. Gastroenterol 1994; 106: 65-72. Vaʻai faʻamatala.
  102. Elmer GW, McFarland LV, Surawicz CM, et al. Amioga o Saccharomyces boulardii i gasegase toe oso Clostridium difficile tagata mamaʻi. Aliment Pharmacol Ther 1999; 13: 1663-8. Vaʻai faʻamatala.
  103. Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia i se tagata maʻi ua mauaina le ultra-levure togafitiga. Clin Infect Dis Dis 1998; 27: 222-3. Vaʻai faʻamatala.
  104. Pletinex M, Legein J, Vandenplas Y. Fungemia ma Saccharomyces boulardii i se teineititi e 1-tausaga le matua na maua i le manava tata. J Pediatr Gastroenterol Nutr 1995; 21: 113-5. Vaʻai faʻamatala.
  105. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii mo Clostridium difficile-fesoʻotaʻi enteropathies i pepe. J Pediatr Gastroenterol Nutr 1993; 16: 419-25. Vaʻai faʻamatala.
  106. Surawicz CM, Elmer GW, Speelman P, et al. Puipuia o manava faʻafesoʻotaʻi e ala ile Saccharomyces boulardii: ose suʻesuʻega faamoemoeina. Gastroenterology 1989; 96: 981-8. Vaʻai faʻamatala.
  107. Surawicz CM, McFarland LV, Elmer G, et al. Togafitiga o le toe tupu clostridium difficile colitis ma le vancomycin ma Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-7. Vaʻai faʻamatala.
  108. McFarland LV, Surawicz CM, Greenberg RN, et al. Puipuia o le manava tata beta-lactam e Saccharomyces boulardii faʻatusatusa i le placebo. Am J Gastroenterol 1995; 90: 439-48. Vaʻai faʻamatala.
  109. McFarland LV, Surawicz CM, Greenberg RN, et al. Ole faʻataʻitaʻiga ole faʻataʻitaʻiga ole faʻataʻitaʻiga ole Saccharomyces boulardii faʻatasi ai ma vailaʻau masani mo vailaʻau ole Clostridium difficile. JAMA 1994; 271: 1913-8. Vaʻai faʻamatala.
  110. Elmer GW, McFarland LV. Faʻamatalaga e uiga i le le lava o togafitiga togafitiga o Saccharomyces boulardii i le puipuia o faʻamaʻi e fesoʻotaʻi ma vailaʻau faʻafomaʻi i tagata matutua. J Infect 1998; 37: 307-8. Vaʻai faʻamatala.
  111. Lewis SJ, Potts LF, Barry RE. Le le lava o togafitiga togafitiga o Saccharomyces boulardii i le puipuia o le manava faʻafesoʻotaʻi-fesoʻotaʻi i tagata matutua tagata mamaʻi. J Infect 1998; 36: 171-4. Vaʻai faʻamatala.
  112. Bleichner G, Blehaut H, Mentec H, et al. Saccharomyces boulardii puipuia le manava tatali i gasegase ogaoga gasegase-fafagaina gasegase. Vaʻaia Fafo Med 1997; 23: 517-23. Vaʻai faʻamatala.
  113. Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease taofia le aafiaga o clostridium difficile oona A ma le B i le tagata colonic mucosa. Siama ma Puipuiga 1999; 67: 302-7. Vaʻai faʻamatala.
  114. Saavedra J. Probiotics ma faʻamaʻi manava tata. Am J Gastroenterol 2000; 95: S16-8. Vaʻai faʻamatala.
  115. McFarland LV. Saccharomyces boulardii e le o le Saccharomyces cerevisiae. Clin Infect Dis Dis 1996; 22: 200-1. Vaʻai faʻamatala.
  116. McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Faʻailogaina faʻamaoniga ma uiga leaga o Saccharomyces boulardii (nom. Inval.). J Clin Microbiol 1998; 36: 2613-7. Vaʻai faʻamatala.
  117. Niault M, Thomas F, Prost J, et al. Fungemia e mafua mai i le Saccharomyces ituaiga i se tagata maʻi ua togafitia i le enteral Saccharomyces boulardii. Clin Infect Dis Dis 1999; 28: 930. Vaʻai faʻamatala.
  118. Bassetti S, Frei R, Zimmerli W.Fungemia ma Saccharomyces cerevisiae i le maeʻa ai o togafitiga ma Saccharomyces boulardii. Am J Med 1998; 105: 71-2. Vaʻai faʻamatala.
  119. Scarpignato C, Rampal P. Puipuiga ma le togafitia o le tagata malaga o le manava tata: O se falemaʻi falemaʻi falemaʻi. Chemotherapy 1995; 41: 48-81. Vaʻai faʻamatala.
Toe iloiloga - 11/10/2020

Mataupu Lata Mai

Apert syndrome
VailaʻAu

Apert syndrome

Apert yndrome o e faamaʻi o le kenera lea e oʻo ai le ooga i le va o ponaivi ponaivi nai lo ma ani. E afaina ai le ulu ma foliga. Tamaiti e maua i le Apert yndrome e tele na i ai ni faʻaletonu o lima ...
Eletise eletise
VailaʻAu

Eletise eletise

O le electrocardiogram (EKG) o e uʻega faigofie, e leai e tiga e fua ai faʻailo eleti e i lou fatu. O taimi uma e tata ai lou fatu, o e faailo eleti e e alu i totonu o le fatu. E mafai ona faʻaalia e ...